MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, BOLT made $2,169,000 in revenue. -$7,148,000 in net income. Net profit margin of -329.55%.

Income Overview

Revenue
$2,169,000
Net Income
-$7,148,000
Net Profit Margin
-329.55%
EPS
-$3.72
Unit: Dollar

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration revenue
2,169,000 1,804,000 1,222,000 2,183,000
Research and development
6,535,000 7,498,000 9,512,000 14,561,333.333
General and administrative
3,337,000 3,516,000 3,825,000 4,886,000
Impairment charges
---367,250
Restructuring charges
0 0 -835,750
Total operating expense
9,872,000 11,014,000 13,337,000 21,051,333.333
Loss from operations
-7,703,000 -9,210,000 -12,115,000 -18,868,333.333
Interest income, net
477,000 599,000 1,053,000 1,718,916.667
Other income
82,000 50,000 22,000 1,168,750
Total other income, net
559,000 649,000 1,075,000 2,887,666.667
Net loss
-7,144,000 -8,561,000 -11,040,000 -15,980,666.667
Net unrealized (loss) gain on marketable securities
-4,000 -46,000 -57,000 -63,000
Comprehensive loss
-7,148,000 -8,607,000 -11,097,000 -16,043,666.667
Earnings per share, basic, total
-3.72 -4.46 -0.29 -0.417
Earnings per share, diluted, total
-3.72 -4.46 -0.29 -0.417
Weighted average common shares outstanding - basic
1,919,441 1,917,629 38,339,697 -22,350.333
Weighted-average shares outstanding, diluted
1,919,441 1,917,629 38,339,697 -22,350.333
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$7,148,000 Other income$82,000 Interest income, net$477,000 Net unrealized(loss) gain on...-$4,000 Net loss-$7,144,000 Total other income,net$559,000 Loss from operations-$7,703,000 Collaboration revenue$2,169,000 Total operatingexpense$9,872,000 General andadministrative$3,337,000 Research and development$6,535,000

Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics, Inc. (BOLT)